Key result
Continuous ECG ST-episodes linked to ~7-fold higher 30-day cardiac death or MI.
Why the study?
Patients with chest pain and an ECG nondiagnostic of AMI constitute a heterogeneous group, and the prognostic importance of continuous 12-lead ECG ST-segment monitoring had not been thoroughly studied in this population.
Does ST-segment monitoring with continuous 12-lead ECG for 12 hours predict cardiac death or myocardial infarction in patients admitted to the CCU with chest pain and an ECG nondiagnostic of acute myocardial infarction?
Cohort (n=630)
No
Does ST-segment monitoring with continuous 12-lead ECG for 12 hours predict cardiac death or myocardial infarction in patients admitted to the CCU with chest pain and an ECG nondiagnostic of acute myocardial infarction?
Continuous 12-lead ECG ST-segment monitoring for 12 hours independently predicts cardiac death or myocardial infarction, improving early risk stratification in chest pain patients with nondiagnostic initial ECGs.
Answers are grounded in this paper and cite their sources.
May enhance early risk stratification in CCU patients; hypothesis-generating and should not yet change practice pending prospective trials.
OBJECTIVES The purpose of this study was to evaluate the prognostic importance of ischemic episodes detected by ST-segment monitoring with continuous 12-lead electrocardiography (ECG) in a nonselected coronary care unit (CCU) population with chest pain and ECG nondiagnostic of acute myocardial infarction (AMI). BACKGROUND Patients with chest pain and ECG nondiagnostic of AMI constitute a heterogeneous group concerning both diagnosis and prognosis. Continuous 12-lead ECG is a rather new method not thoroughly studied in this population. METHODS The ST-segment monitoring with continuous 12-lead ECG was performed for 12 h in 630 consecutive patients admitted to CCU due to chest pain and a nondiagnostic ECG, i.e., no ST-segment elevations. An ST-episode was defined as a transient ST-segment depression or elevation of at least 0.10 mV. The median follow-up time was six months. RESULTS A total of 176 ST-episodes occurred in 100 (15.9%) patients. The median duration and maximal ST-segment deviation in patients with ST-episodes were 80 min and 0.20 mV, respectively. Presence of ST-episodes predicted worse outcome concerning cardiac death and cardiac death or myocardial infarction (MI) (log-rank p < 0.001). At 30 day follow-up procedure, 10% versus 1.5% died from cardiac causes or had an MI in the group with and without ST-episodes, respectively. In a multivariate analysis, only troponin T > or = 0.10 microg/l and the presence of ST-episodes came out as independent predictors of cardiac death or MI. CONCLUSIONS Continuous 12-lead ECG monitoring provides prognostic information on-line and considerably improves early risk stratification in patients with ECG nondiagnostic of AMI and symptoms suggestive of acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Jernberg et al. (1999) conducted a cohort in Chest pain with ECG nondiagnostic of acute myocardial infarction (n=630). Ischemic ST-episodes on 12-hour continuous 12-lead ECG monitoring vs. Absence of ST-episodes was evaluated on Cardiac death or myocardial infarction at 30 days (p=<0.001). ST-episodes detected on continuous 12-lead ECG monitoring predicted higher 30-day cardiac death or MI compared with no ST-episodes.
Synapse has enriched 10 related papers. Consider them for comparative context: